Cargando…

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial

AIMS: To clarify the efficacy and safety of adding sitagliptin to insulin therapy in Japanese patients with suboptimally controlled type 2 diabetes (T2DM). STUDY DESIGN AND METHODS: This was a 24-week, prospective, randomized, open-labeled, controlled trial. Patients with T2DM who were suboptimally...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Seiji, Saisho, Yoshifumi, Kou, Kinsei, Meguro, Shu, Tanaka, Masami, Irie, Junichiro, Kawai, Toshihide, Itoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376939/ https://www.ncbi.nlm.nih.gov/pubmed/25816296 http://dx.doi.org/10.1371/journal.pone.0121988

Ejemplares similares

Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysis
por: Sugiyama, Kazutoshi, et al.
Publicado: (2019)

Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients
por: Tanaka, Masami, et al.
Publicado: (2014)

Past Obesity as well as Present Body Weight Status Is a Risk Factor for Diabetic Nephropathy
por: Meguro, Shu, et al.
Publicado: (2013)

Relationship between Stage of Diabetic Retinopathy and Pulse Wave Velocity in Japanese Patients with Type 2 Diabetes
por: Tanaka, Kumiko, et al.
Publicado: (2013)

Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas
por: Inaishi, Jun, et al.
Publicado: (2016)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report
por: Sasaki, Hironobu, et al.
Publicado: (2022)

Association of Maternal Factors with Perinatal Complications in Pregnancies Complicated with Diabetes: A Single-Center Retrospective Analysis
por: Endo, Sho, et al.
Publicado: (2018)

Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis
por: Meguro, Shu, et al.
Publicado: (2014)

Relationships between Composition of Major Fatty Acids and Fat Distribution and Insulin Resistance in Japanese
por: Fujii, Chikako, et al.
Publicado: (2017)

Association of visit‐to‐visit glycemic variability with risk of cardiovascular diseases in high‐risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial
por: Sato, Midori, et al.
Publicado: (2021)

Clinical utility of 1‐month postpartum random plasma glucose and glycated hemoglobin combined with pre‐pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes
por: Sugiyama, Kazutoshi, et al.
Publicado: (2021)

C-Reactive Protein, High-Molecular-Weight Adiponectin and Development of Metabolic Syndrome in the Japanese General Population: A Longitudinal Cohort Study
por: Saisho, Yoshifumi, et al.
Publicado: (2013)

Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes
por: Tajiri, Yuji, et al.
Publicado: (2014)

Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
por: Sasaki, Hironobu, et al.
Publicado: (2020)

Sitagliptin added to stable insulin therapy with or without metformin in Chinese patients with type 2 diabetes
por: Shankar, R Ravi, et al.
Publicado: (2016)

A case of hypoglycemic hemiparesis and literature review
por: Yoshino, Tetsuhiro, et al.
Publicado: (2012)

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study
por: Takai, Masahiko, et al.
Publicado: (2019)

Longitudinal changes in pancreatic volume and pancreatic fat with weight gain in Japanese without diabetes: An analysis using health check-up data
por: Sunouchi, Maria, et al.
Publicado: (2023)

One-year eGFR decline rate is a good predictor of prognosis of renal failure in patients with type 2 diabetes
por: NOJIMA, Jun, et al.
Publicado: (2017)

Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
por: Shi, Chunhong, et al.
Publicado: (2019)

CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2018)

Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
por: Tajima, Naoko, et al.
Publicado: (2013)

Author Correction: CD44 variant inhibits insulin secretion in pancreatic β cells by attenuating LAT1-mediated amino acid uptake
por: Kobayashi, Nana, et al.
Publicado: (2020)

Efficacy and safety of sitagliptin in Japanese patients with type 2 diabetes switched from glinides
por: Tanaka, Tsuyoshi, et al.
Publicado: (2013)

Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
por: Sasaki, Hironobu, et al.
Publicado: (2021)

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
por: Kashiwagi, Atsunori, et al.
Publicado: (2011)

Efficacy and Safety of Sitagliptin in Japanese Patients With Type 2 Diabetes
por: Ohmura, Hirotoshi, et al.
Publicado: (2015)

Association of glucose tolerance status with pancreatic β‐ and α‐cell mass in community‐based autopsy samples of Japanese individuals: The Hisayama Study
por: Inaishi, Jun, et al.
Publicado: (2020)

One‐year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end‐points in high‐risk Japanese patients
por: Meguro, Shu, et al.
Publicado: (2020)

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
por: Kubota, Akira, et al.
Publicado: (2012)

Antepartum Oral Disposition Index as a Predictor of Glucose Intolerance Postpartum
por: Saisho, Yoshifumi, et al.
Publicado: (2012)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
por: Kaku, Kohei, et al.
Publicado: (2021)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Efficacy of Combination Therapy With Sitagliptin and Low-Dose Glimepiride in Japanese Patients With Type 2 Diabetes
por: Ishii, Hiroaki, et al.
Publicado: (2014)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Fasting serum insulin levels and insulin resistance are associated with blood rheology in Japanese young adults without diabetes
por: Yoshida, Kensuke, et al.
Publicado: (2016)

Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
por: Katsuno, Tomoyuki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5muhec2lsllhdijjljp56frol9